Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Azalea A, Khan"'
Publikováno v:
Nanotheranostics
Extracellular vesicles (EVs) such as exosomes and microvesicles have gained recent attention as potential biomarkers of disease as well as nanomedicinal tools, but their behaviour in vivo remains mostly unexplored. In order to gain knowledge of their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49b301cc7f711856cd49d70d7574448
https://doi.org/10.7150/ntno.51676
https://doi.org/10.7150/ntno.51676
Autor:
Azalea A. Khan, Rafael Torres Martin de Rosales, Amaia Carrascal-Miniño, Francis Man, Philip J. Blower
Publikováno v:
Nuclear Medicine and Biology. :31-40
BACKGROUND Advances in immunology and cell-based therapies are creating a need to track individual cell types, such as immune cells (neutrophils, eosinophils, chimeric antigen receptor (CAR) T cells, etc.) and stem cells. As the fate of administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e679c0b6ebdcdfb668df80a529bbb887
https://doi.org/10.1016/j.nucmedbio.2020.09.002
https://doi.org/10.1016/j.nucmedbio.2020.09.002
Autor:
Azalea A, Khan, Francis, Man, Farid N, Faruqu, Jana, Kim, Fahad, Al-Salemee, Amaia, Carrascal-Miniño, Alessia, Volpe, Revadee, Liam-Or, Paul, Simpson, Gilbert O, Fruhwirth, Khuloud T, Al-Jamal, Rafael, T M de Rosales
Publikováno v:
Bioconjugate chemistry. 33(3)
Exosomes or small extracellular vesicles (sEVs) are increasingly gaining attention for their potential as drug delivery systems and biomarkers of disease. Therefore, it is important to understand their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2c2962ddeff435eae43ee8ee2ba286cc
https://pubmed.ncbi.nlm.nih.gov/35224973
https://pubmed.ncbi.nlm.nih.gov/35224973
Autor:
Francis, Man, Azalea A, Khan, Amaia, Carrascal-Miniño, Philip J, Blower, Rafael, T M de Rosales
Publikováno v:
Nuclear medicine and biology
Background Advances in immunology and cell-based therapies are creating a need to track individual cell types, such as immune cells (neutrophils, eosinophils, chimeric antigen receptor (CAR) T cells, etc.) and stem cells. As the fate of administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f562dcd2af7435de8fd7c44b5691f09
https://pubmed.ncbi.nlm.nih.gov/32979725
https://pubmed.ncbi.nlm.nih.gov/32979725
Autor:
West SJ; From the *University College London and †University College Hospital, London, United Kingdom., Mari JM, Khan A, Wan JH, Zhu W, Koutsakos IG, Rowe M, Kamming D, Desjardins AE
Publikováno v:
Regional anesthesia and pain medicine [Reg Anesth Pain Med] 2014 Sep-Oct; Vol. 39 (5), pp. 429-33.